-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Bicara Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2023 to Q3 2025.
- Bicara Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $3.61M, a 77.9% increase year-over-year.
- Bicara Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $13.7M.
- Bicara Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2024 was $7.4M, a 290% increase from 2023.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)